The effect of cisplatin on human larynx carcinoma cell motility

Folia Histochemica et Cytobiologica

Volumn 47, Issue 1, 2009, Pages 75-79

  Paduch, Roman ^a   Rzeski, Wojciech ^a,b   Klatka, Janusz ^c  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Cell culture; Cisplatin; Laryngeal carcinoma; Tumor cell motility

Indexed keywords

CISPLATIN; LUCIFER YELLOW;

ADULT; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CELL COMMUNICATION; CELL MIGRATION; CELL MOTILITY; CELL SPECIFICITY; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GAP JUNCTION; HUMAN; HUMAN CELL; LARYNX CARCINOMA; MALE; MIGRATION INHIBITION; MONOLAYER CULTURE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; CISPLATIN; DIFFUSION; FEMALE; HUMANS; ISOQUINOLINES; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED;

EID: 66449115516     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0022-2     Document Type: Article

References (14)

1. Devlin JG, Langer CJ. Combined modality treatment of laryngeal squamous cell carcinoma. Expert Rev Anticancer Ther. 2007;7:331-350.
2. Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D, Stromboni-Luboinski M, Hill C. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol. 1998;34:224-228.
3. Jakubowicz-Gil J, Paduch R, Gawron A, Kandefer-Szerszeń M. The effect of cisplatin, etoposide and quercetin on Hsp72 expression. Pol J Pathol. 2002;53:133-137.
4. Jakubowicz-Gil J, Paduch R, Gawron A, Kandefer-Szerszeń M. The effect of heat shock, cisplatin, etoposide and quercetin on Hsp27 expression in human normal and tumour cells. Folia Histochem Cytobiol. 2002;40:31-35.
5. Paduch R, Słotwińska M, Stachura A, Rzeski W, Zdzisińska B, Kandefer-Szerszeń M. Comparative analysis of different methodological approaches to the in vitro study of tumour cells chemosensitivity. Ann Univ Mariae Curie-Sklodowska [Biol]. 2001;LVI:7-19.
6. Bruzzone R, White TW, Paul DL. Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem. 1996;238:1-27.
7. Procházka L, Turánek J, Tesařik R, Knotigová P, Polášková P, Andrysík Z, Kozubík A, Žák F, Sova P, Neuzil J, Machala M. Apoptosis and inhibition of gap-junctional intercellular communication induced by LA-12, a novel hydrophobic platinum (IV) complex. Arch Biochem Biophys. 2007;462:54-61.
8. Rzeski W, Paduch R, Klatka J, Kandefer-Szerszeń M, Stepulak A, Pozarowski P, Zdzisińska B. Establishment and preliminary characterization of two cell lines derived from larynx carcinoma. Folia Histochem Cytobiol. 2002;40:195-196.
9. Rzeski W, Matysiak J, Kandefer-Szerszeń M. Anticancer, neuroprotective activities and computational studies of 2-amino-1,3,4-thiadiazole based compound. Bioorg Med Chem. 2007;15:3201-3207.
10. Wernyj RP, Morin PJ. Molecular mechanisms of platinum resistance: still searching for the Achilles' heel. Drug Resist Updates. 2004;7:227-232.
11. Klatka J, Paduch R, Pozarowski P, Pietruszewska W, Kupisz K, Trojanowski P, Roliński J. Application of primary cell cultures of laryngeal carcinoma and laser scanning cytometry in the evaluation of tumor reactivity to cisplatinum. Folia Histochem Cytobiol. 2008;46:159-164.
12. Klatka J, Paduch R, Pozarowski P, Borzecka H, Rogowski M. Expression of syndecan-1 in primary cultures of laryngeal carcinoma cells after the incubation with cisplatin. Pol J Environ Stud. 2005;14,Suppl II:202-205.
13. Jensen R, Glazer PM. Cell-interdependent cisplatin killing by Ku/ DNA-dependent protein kinase signaling transduced through gap junctions. Proc Natl Acad Sci USA. 2004;101:6134-6139.
14. Lee SH, Tomasetto C, Paul D, Keyomarsi K, Sager R. Transcriptional down-regulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J Cell Biol. 1992; 118:1213-1221.